TEC Edmonton’s Technology Management team offers expert advice on intellectual property matters which often lead to new patents, licensing agreements and company spin-offs.
Small Molecule Inhibitors of Polynucleotide Kinase/Phosphatase, Poly(ADP-RIBOSE) Polymerase and Uses Thereof U.S. Patent No. 9,040,551, issued May 26th 2015
This patent covers new inhibitors of polynucelotide kinase/phosphatase (PNKP), a DNA repair enzyme and emerging cancer therapy target. The inventors, Drs. Michael Weinfeld, Gary Freschauf, Feridoun Karimi-Busheri and Todd Mereniuk (UA Oncology), and Dr. Dennis Hall (UA Chemistry) are building on their extensive expertise with PNKP to design and test a series of compounds that will make cancer cells more sensitive to chemo and radiation therapy.
Their work has received support from the Canadian Institutes of Health Research, the Centre for Drug Research and Development (CDRD, Vancouver BC) and the Alberta Cancer Foundation.
Two-and Three-Terminal Molecular Electronic Devices with Ballistic Electron Transport U.S. Patent No. 9,023,812, issued May 5, 2015
Dr. Richard McCreery from the University of Alberta’s Department of Chemistry received an issued U.S. patent describing a molecular electronic junction that permits rapid, non-resistive transport. The operating principle is based on tunneling and ballistic transport, thus permitting high speed, low power consumption and minimal heat generation.
These devices may provide smaller and more efficient alternatives to the semiconductor industry, specifically in computers and display devices, among others.
Methods for Producing Fuels and Solvents Substantially Free of Fatty Acids U.S. patent No. 8,975,457, issued March 10, 2015
Dr. David Bressler of the University of Alberta’s Department of Agricultural, Food and Nutritional Science received a patent describing a new biorefining technique to purify fuels produced from agricultural waste materials by pyrolysis (heating without oxygen). This purification process separates fuels from any remaining feedstock to produce high quality biofuels that meet industry and regulatory standards. The technology can also recover high value co-products if desired and is part of a second family of patents related to the pyrolysis process.
This technology is currently licensed to Forge Hydrocarbons Corporation.
A University of Alberta technology developed by Dr. Diane Taylor has been sublicensed by licensee Ratiopharm to Glycom, a Denmark-based company.
The licensed technology relates to α1,2-fucosyltransferase proteins originally isolated from the human gut pathogen Helicobacter pylori and useful for the enzymatic production of 2’-fucosyllactose. Glycom will initially develop the technology to produce 2’-fucosyllactose, a sugar abundant in human breast milk, for use in infant formula manufacturing.
TB/HIV Research Foundation (THRF)
TEC Edmonton has successfully negotiated an Inter-Institutional Agreement between the University of Alberta and the TB/HIV Research Foundation (THRF), a non-profit organization in Thailand.
Through a collaborative research project of the Alberta Innovates Centre for Machine Learning, funded by Alberta Innovates Technology Futures, Dr. Yutaka Yasui from the School of Public Health, University of Alberta, and researchers from THRF developed a novel software algorithm for automated serial image analysis along with an inexpensive and effective machine for detection of the pathogen Mycobacterium tuberculosis. M. tuberculosis is the causative agent of tuberculosis (TB), which remains a major global health concern.
In order to make the technology readily available to individuals in endemic regions, this agreement grants THRF a royalty-free license to commercialize the technology in Thailand and other TB high-burden countries.
Edmonton, AB –June 23, 2015–TEC Edmonton is pleased to announce the appointment of two most distinguished Albertans, Dave Hancock and Kristina Williams, to the TEC Edmonton Board of Directors.
Through his 18 years as a member of the Legislative Assembly of Alberta and as a cabinet minister, former Alberta Premier Dave Hancock never ceased to champion technology, innovation, research and education.
Dave developed the provincial 20-year strategic plan that called for unleashing innovation, among other initiatives. As minister of innovation and advanced education, he collaborated with many sector leaders to commercialize initiatives from traditional industries like oil & gas, forestry and agriculture, as well as IT, biosciences and life sciences.
Now counsel to the law firm Dentons Canada LLP, Dave continues to engage and advance opportunities in innovation and technology.
“I am excited to join TEC Edmonton,” says Hancock. “It’s one of Canada’s leading business incubators with a great innovation network. The TEC Edmonton partnership provides a hand up for entrepreneurs and inventors, making our knowledge economy possible. I hope my passion for the innovation sector and my experience will add value to the TEC Edmonton board and its clients.”
Kristina Williams is President and Chief Executive Officer of Alberta Enterprise Corporation (AEC). She oversees the $100 million Alberta Enterprise Fund, set up by the Government of Alberta in 2008 to invest in venture capital funds that, in turn, finance early-stage technology companies.
AEC has invested in eight such venture capital funds plus the province’s Accelerate Fund and an angel co-investment fund.
Prior to joining Alberta Enterprise, Kristina worked for several technology companies. Her responsibilities have spanned legal, regulatory, international and new business development, corporate strategic planning, intellectual property management plus marketing and sales.
Kristina holds an MBA from the University of Alberta, a Master of Laws from the University of Uppsala, and accreditation for the Venture Capital Executive Program from the University of California, Berkeley – Walter A. Haas School of Business. She is also Honorary Consul for Sweden in Northern Alberta.
“I am honoured to join the TEC Edmonton Board,” says Williams. “TEC Edmonton is an integral part of Alberta’s early startup value chain. By grooming young entrepreneurial companies for growth, business expansion and investment, TEC Edmonton feeds those companies into the venture capital value chain that Alberta Enterprise continues to build.”
“I am pleased to have two such outstanding people joint the TEC Edmonton Board,” says TEC Edmonton CEO Chris Lumb. “Edmonton is fast becoming recognized as one of Canada’s leading technology entrepreneurship regions, and the addition of Dave and Kristin to our board will further strengthen this reputation.”
ABOUT TEC EDMONTON
TEC Edmonton helps technology entrepreneurs accelerate their growth. In addition to being the commercialization agent for University of Alberta technologies, TEC Edmonton operates Greater Edmonton’s largest accelerator for early stage technology companies, including both university spinoffs and companies from the broader community.
TEC provides client services in four broad areas: Business development, funding and finance, technology commercialization and entrepreneur development.
TEC’s ~125 active clients are an outstanding group of companies. Since 2011, TEC clients have generated $310M in revenue, raised $160M in financing and funding, invested $85M in R&D, grown both revenue and employment by 25% per year and now employ over 1800 people in the region. In addition, TEC has assisted in the creation of 14 spinoffs from the University in the last three years.
Finally, the principals of TEC VenturePrize 2015 winner Sensassure have made a series of YouTube videos detailing their day-by-day experience as they live in an extended care home in order to gain first-hand experience to improve their incontinence management product. Sensassure uses a wireless sensor to detect moisture levels in adult incontinence padding – a device that will both save much attendant time during “check ‘n’ change” rounds, and provide faster relief for those actually suffering incontinence in extended care situations
TEC Edmonton’s use of Executives-in-Residence and Business Development Associates to deliver business services to its clients.
All three panel participants, Lumb says, emphasized the need to measure outcomes, to empirically show how their organizations have benefited their business clients.
“Some in the audience said they simply did not have the resources to measure their performance. Our universal answer was ‘you have no choice, you have to measure your performance.’
“Stakeholders need objective metrics to know how the organization they may fund or otherwise encourage is doing. That was an eye-opener for quite a few attendees.”
Lumb fielded several questions about TEC Edmonton’s governance, still quite unique, as a joint venture between the University of Alberta and the City of Edmonton to encourage and assist technology commercialization and business development at the University and from the community-at-large.
“Most were amazed that such a joint venture was possible,” says Lumb, “that such unity and cohesion of purpose could happen between a university and its city in support of the common cause.
“My response to ‘how did you do it?’ was that Edmonton is an exceptionally innovative city where both the University and the City believe entrepreneurship and innovation is critical to the long-term success of both. The lively spirit of the partnership speaks to the character of our city as a whole.”
TEC Edmonton’s policy of employing short-term Executives-in-Residence and Business Development Associates to deliver its business services interested many in the audience.
“Many questions were asked about our encouragement of TEC’s Executives-in-Residence and business associates to leave TEC and move to entrepreneurial ventures after a number of years.”
To learn more about TEC Edmonton, how it does business and measures its outcomes, please visit www.tecedmonton.com. Don’t hesitate to contact CEO Lumb at (001) 780-492-8318. Follow TEC Edmonton on Facebook, LinkedIn and Twitter @tecedmonton.
Telebivudine to Abrogate Amyotrophic Lateral Sclerosis
Description Telbivudine Dr. Ted Allison and his team at the University of Alberta have discovered that telbivudine, a blood brain barrier-permeable thymidine analogue approved for treatment of Hepatitis B, is......
A Point-of-Care Diagnostic Tool to Replace Chest X-Ray for the Diagnosis of Childhood Pneumonia
Description University of Alberta researchers have discovered a novel set of biomarkers which can be used to diagnose pneumonia in children. The biomarkers include chitinase-3-like-1 (CHI3L1), lipocalin-2 (LCN-2), C-reactive protein......
Novel Cell Isolation Method for Bio-engineering Artificial Cartilage
Description University of Alberta researchers have developed a new method to isolate cells from knee joint (meniscus). The isolated cells are non-contractile in nature and do not form scar tissue.......
Novel Composite Monolith as a New Solid Phase Extraction Material for Environmental Analysis
Description University of Alberta researchers have developed a new material of a composite silica monolith nested in sponge (SiMNS) for solid phase extraction. The application of the new SiMNS material......
Self Assembling Peptide for Activating Human Mast Cells
Description Researchers at the University of Alberta have developed a novel biomaterial that can activate the body’s own innate immune response and accelerate the wound healing process. This technology may......
An Innocuous Structured Scaffold for Prion Disease Vaccines and Antigens
Description Researchers at the University of Alberta, led by Dr. Holger Wille, have developed a novel strategy for the creation of vaccines and specific antigens for prion protein diseases. Applying......
Description Demonstration of stereotactic setup. An example of a commercially-available micromanipulator is shown. The setup can accommodate any micromanipulator design. Dr. Vivian Mushahwar and her team have developed an image-guided......
Method for the Production of Z-Olefins from 1,3-Dienes
Description Dr. Rylan Lundgren has developed a process for formate-mediated production of Z-olefins (also referred to as cis-alkenes) in the presence of a rhodium-based catalyst. The process is highly selective......
A Novel Method to Produce Pitched Kefir for Reducing Cholesterol
Description Researchers at the University of Alberta and TEAGASC have jointly developed a pitched-based method to produce kefir (a fermented milk beverage) that when consumed reduces blood cholesterol levels. The......
Novel F-18 Beta-Hydroxybutyric Acid Radiotracers for PET Imaging
Description Researchers at the University of Alberta have synthesized novel beta-hydroxybutyric acid radiotracers for PET imaging using a 3 step radiosynthetic process. The compounds are designed to serve as radiofluorinated......
A Novel Method for CryoPreservation of Cells in Monolayers
Description Researchers at the University of Alberta have developed a novel method to cryopreserve cells while adhered in a monolayer configuration. This method can preserve cells on a substrate and......
Train-Triggered Alert System for Conditioning and Warning Wildlife
Description Researchers at the University of Alberta have developed a novel, inexpensive, and compact system to alert wildlife to approaching trains, increasing the time available to avoid a collision. Rail-caused......